https://www.selleckchem.com/products/mgh-cp1.html
A total of 13 of 66 patients discontinued BZD anxiolytics during CBT, and 21 of 66 reduced their prescribed dosage by 50%. The association between discontinuation and dose-reduction and assessment period was modeled simultaneously using Bayesian hierarchical hurdle model. Results from the modeling showed a significant discontinuation at post-CBT and at 3 months post-CBT session compared to baseline (estimated median odds ratio [OR] post-CBT = 9.79 [95% CI 4.65-20.45]; OR at 3 months post-CBT = 11.53 [95% CI 6.06-22.33]). Moreover, a sig
Like
Comment
Share
